[1]
“In vitro and in silico studies on novel N-substituted-3,5-diaryl-pyrazoline derivatives as COX-2 inhibitors and anti-inflammatory agents”, IJC, vol. 62, no. 6, pp. 627–633, Jun. 2023, doi: 10.56042/ijc.v62i6.2532.